In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

HHS officials announced they're extending a pandemic-era act that protects doctors, pharmacists and other healthcare ...

Eisai licenses Newron's evenamide for Asia; Novavax gets $50M from Sanofi; Candel & Inovio price offerings; RemeGen's disitamab vedotin shows success in breast cancer trial ...

Sanofi and Novavax are targeting the co-formulation for people 50 years and up.

NVO's CagriSema target of up to 25% in long-term weight loss is highly promising vs. 15% through Wegovy and 20% through ...

Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...

Wataynikaneyap Power is pleased to announce that all assets of the Wataynikaneyap Power transmission system have been energized! The infrastructure megaproject includes 1,800 kilometres of ...